Updated: January 27, 2026
Phenazopyridine Drug Interactions: What to Avoid and What to Tell Your Doctor
Author
Peter Daggett

Overview
Phenazopyridine (Pyridium, AZO) has very few drug-drug interactions—but there are important warnings about urinalysis interference and special populations to know.
Is Phenazopyridine in stock near you?
Medfinder checks real pharmacy inventory — start a search and we'll find Phenazopyridine near you.
One of phenazopyridine's advantages is that it has very few drug-drug interactions. According to clinical literature and StatPearls (NIH), phenazopyridine has no known clinically significant drug-drug or drug-food interactions. However, this doesn't mean it's interaction-free in all ways—there are important factors about how it affects lab tests, certain populations, and theoretical risks that patients and providers should know.
Drug-Drug Interactions: What Does the Evidence Say?
Clinical databases and FDA prescribing information do not list any major drug-drug interactions with phenazopyridine. The drug has no known:
Interactions with common antibiotics (trimethoprim, nitrofurantoin, ciprofloxacin, amoxicillin)
Interactions with blood thinners (warfarin, aspirin)
Interactions with common blood pressure medications, statins, or antidepressants
Interactions with alcohol or common foods
This is actually unusual—most drugs have at least some documented interactions. The relative simplicity of phenazopyridine's pharmacology (it's excreted quickly without significant metabolic interaction) contributes to its clean interaction profile.
Check live stock now.
Theoretical Risk: Local Anesthetics and Methemoglobinemia
There is a theoretical concern—not confirmed in clinical literature—that combining phenazopyridine with other methemoglobin-inducing agents (such as benzocaine, a local anesthetic found in some OTC numbing products) could theoretically increase the risk of methemoglobinemia. However, this interaction has not been confirmed in studies, and phenazopyridine has been used alongside lidocaine gel without reported issues.
Out of caution, avoid combining phenazopyridine with other products that carry a methemoglobin risk without discussing with your provider first.
Critical: Phenazopyridine Interferes With Lab Tests
This is the most practically significant "interaction" patients need to know about. Because phenazopyridine is an azo dye, it interferes with multiple urine-based laboratory tests:
Urine dipstick tests: Can produce false positive or false negative results for glucose, ketones, bilirubin, protein, and other markers measured by color-based reactions
Spectrophotometric assays: The orange dye absorbs light at frequencies used in lab measurements, causing interference
Urine culture: The dye may discolor the urine culture specimen (though it does not typically affect growth of bacteria in culture)
Practical action: Always obtain your urine culture and urinalysis BEFORE starting phenazopyridine. If a urine test is needed while you're taking it, tell your provider and the lab so they can account for this interference.
Special Populations With Heightened Risk
While phenazopyridine has few drug-drug interactions, certain patient populations have physiological conditions that change how phenazopyridine behaves and increase the risk of serious adverse effects:
Kidney disease: Phenazopyridine is renally cleared. Impaired kidney function leads to drug accumulation, which can cause yellowing of the skin/eyes, methemoglobinemia, and renal toxicity. CONTRAINDICATED in renal insufficiency.
G6PD deficiency: Glucose-6-phosphate dehydrogenase deficiency increases susceptibility to oxidative hemolysis. Phenazopyridine can trigger hemolytic anemia in these patients. Should be avoided.
Elderly patients: Age-related decline in renal function increases accumulation risk. Monitor more carefully; use the lowest effective duration.
Pregnant patients: FDA Pregnancy Category B (animal studies no harm; no adequate human studies). Use only if clearly needed and under medical guidance.
Breastfeeding: It's unknown whether phenazopyridine passes into breast milk. Avoid while breastfeeding, especially with infants under 1 month old or those with G6PD deficiency.
What to Tell Your Doctor Before Taking Phenazopyridine
Any history of kidney disease or chronic kidney disease (CKD)
Known G6PD deficiency
Pregnancy or breastfeeding status
Any planned urine lab tests or imaging procedures requiring urine samples
Use of benzocaine-containing topical products (theoretical interaction)
All current medications, including OTC drugs and supplements (even if no known interaction, your provider should have a complete picture)
For information on phenazopyridine side effects and warning signs to watch for, see: Phenazopyridine Side Effects: What to Expect and When to Call Your Doctor.
Frequently Asked Questions
No significant drug-drug interactions between phenazopyridine and common UTI antibiotics (trimethoprim-sulfamethoxazole, nitrofurantoin, ciprofloxacin, amoxicillin) have been documented. Phenazopyridine is routinely co-prescribed alongside these antibiotics for UTI treatment. Always tell your provider all medications you are taking.
Yes—this is the most important 'interaction' to know. Phenazopyridine's azo dye properties interfere with urine dipstick tests and spectrophotometric assays, producing false results for glucose, ketones, bilirubin, and other markers. Always get your urine culture and urinalysis before starting phenazopyridine. Tell your provider and the lab if you are taking it when urine testing is ordered.
No. Phenazopyridine is contraindicated in renal insufficiency. Because it is cleared by the kidneys, impaired kidney function causes the drug to accumulate to toxic levels, risking yellowing of the skin/eyes, methemoglobinemia, and renal damage. Patients with kidney disease should use acetaminophen for UTI pain relief instead (after consulting their provider).
There are no documented interactions between phenazopyridine and alcohol. However, alcohol can irritate the bladder and worsen UTI symptoms, so it is generally advisable to avoid alcohol while symptomatic with a UTI regardless of whether you are taking phenazopyridine.
Phenazopyridine is classified as FDA Pregnancy Category B—animal studies show no fetal harm, but adequate human studies have not been conducted. It should only be used during pregnancy if clearly needed and under a doctor's guidance. Do not use OTC AZO or Uristat during pregnancy without discussing it with your provider first.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Phenazopyridine also looked for:
More about Phenazopyridine
38,224 have already found their meds with Medfinder.
Start your search today.
Your information is private and never shared.





